Medicare Enrolled
Dr. Christine Simone, M.D.
Hematology & Oncology · Stuart, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simone? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Simone
Dr. Christine Simone is a hematology & oncology in Stuart, FL, with 15 years in practice. Based on federal Medicare data, Dr. Simone performed 83,488 Medicare services across 3,601 unique beneficiaries.
Between the years covered by Open Payments, Dr. Simone received a total of $44,249 from 103 pharmaceutical and/or device companies across 1445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Simone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 10% volume in FL$ $44,249 industry payments
Medicare Practice Summary
Medicare Utilization ↗83,488
Medicare services
Top 10% in FL for hematology & oncology
3,601
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,566 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 33,750 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 12,000 | $42 | $105 |
| Paclitaxel chemotherapy injection | 6,954 | $0 | $2 |
| Injection, eflapegrastim-xnst, 0.1 mg | 5,161 | $25 | $82 |
| Dexamethasone injection (steroid) | 5,076 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 4,380 | $18 | $38 |
| Epoetin alfa injection (Retacrit) for anemia | 2,260 | $6 | $22 |
| Complete blood count (CBC) with differential | 2,207 | $8 | $40 |
| Comprehensive metabolic blood panel | 1,369 | $10 | $40 |
| Office visit, established patient (30-39 min) | 1,211 | $100 | $175 |
| Infusion, normal saline solution, 250 cc | 653 | $1 | $6 |
| Injection, magnesium sulfate, per 500 mg | 644 | $1 | $3 |
| Injection, carboplatin, 50 mg | 572 | $2 | $15 |
| Administration of chemotherapy into vein, 1 hour or less | 519 | $107 | $330 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 514 | $24 | $76 |
| Injection, potassium chloride, per 2 meq | 505 | $0 | $6 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 444 | $3 | $48 |
| Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 444 | $100 | $628 |
| Magnesium level test | 440 | $7 | $15 |
| Drug injection, under skin or into muscle | 366 | $11 | $45 |
| Vitamin B-12 level test | 355 | $15 | $30 |
| Ferritin level test (iron stores) | 348 | $13 | $27 |
| Folic acid level test | 334 | $14 | $29 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 224 | $52 | $150 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 197 | $344 | $1,111 |
| Infusion into a vein for hydration, 31-60 minutes | 183 | $27 | $125 |
| Injection, diphenhydramine hcl, up to 50 mg | 179 | $1 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 157 | $53 | $165 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 149 | $1 | $5 |
| Administration of chemotherapy into vein, each additional hour | 138 | $23 | $78 |
| Hospital follow-up visit, high complexity | 125 | $99 | $185 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 124 | $16 | $50 |
| Thyroid stimulating hormone (TSH) test | 113 | $16 | $34 |
| Office visit, established patient (20-29 min) | 113 | $59 | $111 |
| Office visit, established patient, complex (40-54 min) | 113 | $147 | $251 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 108 | $59 | $135 |
| Lactate dehydrogenase (enzyme) level | 103 | $6 | $15 |
| Carcinoembryonic antigen (cea) protein level | 102 | $19 | $38 |
| Phosphate level test | 100 | $5 | $11 |
| New patient office visit, complex (60-74 min) | 97 | $176 | $364 |
| Infusion into a vein for hydration, each additional hour | 96 | $11 | $40 |
| Hospital follow-up visit, moderate complexity | 80 | $66 | $130 |
| Free thyroxine (T4) test | 71 | $9 | $18 |
| Initial hospital admission, high complexity | 69 | $139 | $330 |
| New patient office visit (45-59 min) | 64 | $116 | $300 |
| Injection of additional new drug or substance into vein | 60 | $13 | $56 |
| Blood draw (venipuncture) | 44 | $8 | $15 |
| Telephone medical discussion with physician, 5-10 minutes | 44 | $26 | $100 |
| PSA test (prostate cancer screening) | 36 | $18 | $37 |
| Administration of additional new drug or substance into vein using push technique | 28 | $46 | $138 |
| Irrigation of implanted venous access drug delivery device | 23 | $21 | $54 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 16 | $16 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $48 | $105 |
| Initial hospital admission, moderate complexity | 11 | $109 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.6% high complexity
48.1% medium
9.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$44,249
Total received (2018-2024)
Avg $6,321/year across 7 years
Top 16% in FL for hematology & oncology
103
Companies
1,445
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,459 (55.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19,789 (44.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,379
2023$4,162
2022$3,911
2021$3,513
2020$2,835
2019$13,741
2018$11,709
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$20,181
AstraZeneca Pharmaceuticals LP
$2,218
Janssen Biotech, Inc.
$1,990
E.R. Squibb & Sons, L.L.C.
$1,531
Amgen Inc.
$1,269
Celgene Corporation
$1,210
Astellas Pharma US Inc
$1,118
Genentech USA, Inc.
$1,077
Novartis Pharmaceuticals Corporation
$1,023
Daiichi Sankyo Inc.
$883
GlaxoSmithKline, LLC.
$844
Merck Sharp & Dohme Corporation
$637
GENZYME CORPORATION
$548
Seagen Inc.
$542
Incyte Corporation
$540
Merck Sharp & Dohme LLC
$441
Lilly USA, LLC
$413
Bayer HealthCare Pharmaceuticals Inc.
$403
Pharmacyclics LLC, An AbbVie Company
$369
Gilead Sciences, Inc.
$333
ARRAY BIOPHARMA INC
$273
Exelixis Inc.
$269
Kite Pharma, Inc.
$250
Ipsen Biopharmaceuticals, Inc
$239
Puma Biotechnology, Inc.
$239
Foundation Medicine, Inc.
$210
Coherus Biosciences Inc.
$206
ABBVIE INC.
$198
JAZZ PHARMACEUTICALS INC.
$191
Bayer Healthcare Pharmaceuticals Inc.
$190
Eisai Inc.
$190
Boehringer Ingelheim Pharmaceuticals, Inc.
$182
Takeda Pharmaceuticals U.S.A., Inc.
$182
Kyowa Kirin, Inc.
$176
Medtronic, Inc.
$175
Pharmacosmos Therapeutics Inc.
$164
Alexion Pharmaceuticals, Inc.
$160
AbbVie, Inc.
$147
PUMA BIOTECHNOLOGY, INC.
$144
Pharmacyclics LLC, an AbbVie Company
$137
BeiGene USA, Inc.
$130
Taiho Oncology, Inc.
$123
Dova Pharmaceuticals
$109
Azurity Pharmaceuticals, Inc.
$108
Mirati Therapeutics, Inc.
$104
Sumitomo Pharma America, Inc.
$95
SERVIER PHARMACEUTICALS LLC
$88
Helsinn Therapeutics (U.S.), Inc.
$86
Karyopharm Therapeutics Inc.
$83
Regeneron Healthcare Solutions, Inc.
$78
PharmaEssentia USA Corporation
$75
Tempus AI, Inc
$74
TESARO, Inc.
$73
Agios Pharmaceuticals, Inc.
$68
Stemline Therapeutics Inc.
$68
TerSera Therapeutics LLC
$64
MEDIVATION FIELD SOLUTIONS LLC
$61
EMD Serono, Inc.
$57
Heron Therapeutics, Inc.
$56
MorphoSys, US Inc.
$55
AMAG Pharmaceuticals, Inc.
$52
TOLMAR Pharmaceuticals, Inc.
$52
Aveo Pharmaceuticals, Inc.
$52
Fennec Pharmaceuticals, Inc.
$46
SOBI, INC
$42
ACCORD HEALTHCARE, INC.
$42
Rigel Pharmaceuticals, Inc.
$42
Teva Pharmaceuticals USA, Inc.
$41
Clovis Oncology, Inc.
$40
Sobi, Inc
$40
Advanced Accelerator Applications
$36
Octapharma USA, Inc.
$26
Biocon Biologics Inc
$25
Novocure Inc.
$25
Seattle Genetics, Inc.
$25
EUSA Pharma (US) LLC
$24
Mylan Institutional Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Jazz Pharmaceuticals Inc.
$21
Genmab U.S., Inc.
$21
EISAI INC.
$21
AbbVie Inc.
$21
ADC Therapeutics America, Inc.
$20
Apellis Pharmaceuticals, Inc.
$20
Sun Pharmaceutical Industries Inc.
$20
Aurobindo Pharma USA, Inc.
$19
Acceleron Pharma, Inc.
$19
G1 Therapeutics, Inc.
$19
Blueprint Medicines Corporation
$19
Dendreon Pharmaceuticals LLC
$19
Secura Bio, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
Array BioPharma Inc.
$18
Organon LLC
$18
Myriad Genetic Laboratories, Inc.
$17
ImmunoGen, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Verastem, Inc.
$16
Myovant Sciences Inc.
$15
AVEO Pharmaceuticals, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
Midatech Pharma US Inc
$13
Sirtex Medical Inc
$12
Top 3 companies account for 55.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Fulphila · GAZYVA · GILOTRIF · GIVLAARI · Gelclair · Halaven · Hulio · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Poteligeo · Prolia · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · Venclexta · Vitrakvi · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $53 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
18
Per 100K population
11.2
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Simone is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (low-engagement, top 16%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Simone experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Simone performed 33,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simone receive payments from pharmaceutical companies?
Yes. Dr. Simone received a total of $44,249 from 103 companies across 1,445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simone's costs compare to other hematology & oncologys in Stuart?
Dr. Simone's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Stuart
Browse hematology & oncologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology